On World Cancer Research Day, 24 September, we would like to highlight some of the most significant advances made over the past year by Clínic-IDIB...
The EPoS II study, published in the New England Journal of Medicine, provides new evidence on the follow-up of patients after the removal of high-r...
A study led by Hospital Clínic-IDIBAPS sheds light on how this rare type of lymphoma evolves and why some tumor cells eventually outcompete others.
The Recovering Lives, Preventing Social Exclusion project, promoted by Hospital Clínic Barcelona and the Training and Work Foundation (FiT), has co...
RAS inhibitors have opened a new chapter in the treatment of pancreatic cancer, but some tumours develop resistance to these drugs. Here, we explor...
A research project led by Clínic-IDIBAPS is exploring how a simple urine sample could help detect bladder cancer at an early stage in people who sm...
Thomas Walle, head of the IDIBAPS Computational cancer biomedicine group has received a Starting Grant from the European Research Council (ERC) in...
A study led by the IDIBAPS Molecular genetics of paediatric lymphomas research group has identified genetic, biological and clinical differences b...
More precise than conventional radiotherapy, proton therapy reduces radiation exposure to healthy tissues and creates new opportunities for persona...
A systematic review led by Hospital Clínic Barcelona has identified significant differences in gastric cancer between men and women that could supp...
